LIDOCAINE ACCORD 1% lidocaine hydrochloride 100 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 1% lidocaine hydrochloride 100 mg/10 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections; sodium chloride - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

LIDOCAINE ACCORD 2% lidocaine hydrochloride 200 mg/10 mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

lidocaine accord 2% lidocaine hydrochloride 200 mg/10 ml injection ampoule

accord healthcare pty ltd - lidocaine hydrochloride, quantity: 200 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - lidocaine accord solutions are indicated for the production of local or regional anaesthesia by the following techniques: ? infiltration ? intravenous regional anaesthesia ? peripheral nerve block ? epidural block ? subarachnoid block

RETROVIR 100 mg/10ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

retrovir 100 mg/10ml oral solution

viiv healthcare uk ltd - zidovudine - oral solution - 100 mg/10ml - nucleoside and nucleotide reverse transcriptase inhibitors

Milrinone GH 10mg/10 mL Concentrated Injection milrinone (as lactate)10mg/10 mL ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

milrinone gh 10mg/10 ml concentrated injection milrinone (as lactate)10mg/10 ml ampoule

generic health pty ltd - milrinone, quantity: 10 mg - injection, concentrated - excipient ingredients: water for injections; glucose; lactic acid; sodium hydroxide - milrinone gh concentrated injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart failure patients in intensive care and coronary care units not responding to other therapy (eg. digoxin, diuretics, vasodilators, including ace inhibitors). the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. - milrinone gh concentrated injection is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

ORION DIAZEPAM 10mg/10mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

orion diazepam 10mg/10ml oral liquid bottle

orion laboratories pty ltd t/a perrigo australia - diazepam, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: ethanol; propylene glycol; glycerol; citric acid; sodium citrate dihydrate; purified water; flavour - indications as at 30 september 2003: diazepam is indicated in the management of anxiety disorders and for the short term relief of the symptoms of anxiety. diazepam is a useful adjunct for the relief of reflux muscle spasm due to local trauma (injury, inflammation) to muscles, bones and joints. it is also indicated in the management of cerebral spasiticity due to upper motor neuron lesions such as cerebral palsy and paraplegia, and spasticity in athetosis and stiff man syndrome. in acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.

ORION CHLORAL HYDRATE MIXTURE 1g/10mL bottle Australia - English - Department of Health (Therapeutic Goods Administration)

orion chloral hydrate mixture 1g/10ml bottle

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucrose; citric acid; sodium citrate dihydrate; saccharin sodium; glycerol; methyl hydroxybenzoate; ethanol; propylene glycol; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.

BREVIBLOC Esmolol hydrochloride 100mg/10mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

brevibloc esmolol hydrochloride 100mg/10ml injection

phebra pty ltd - esmolol hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium acetate trihydrate; glacial acetic acid - supraventricular tachycardia - for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol is also indicated in non-compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. esmolol is not intended for use in chronic settings where transfer to another agent is anticipated, or for treatment periods greater than 24 hours duration.

FLUOROURACIL ACCORD fluorouracil 500 mg/10 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fluorouracil accord fluorouracil 500 mg/10 ml injection vial

accord healthcare pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas.,fluorouracil should only be used when other proven measures have failed or are considered impractical.